Caredx

This study is testing a new blood test called AlloHeme that can detect tiny amounts of a patient's own cells returning after a bone marrow transplant. The goal is to see if this test can predict a cancer relapse earlier than standard methods. The study involves 307 adults with le…

This study follows 1,500 liver transplant recipients to see if a new blood test called LiverCare can detect problems like organ rejection or infection earlier than standard monitoring. Participants will have their blood tested multiple times over several years. The goal is to imp…

This study follows over 2700 heart transplant recipients to see how well HeartCare testing services work for monitoring organ rejection. Participants are 15 years or older and start testing within 3 months after transplant. The study does not test a new treatment but collects dat…

This study looks at whether a blood test called AlloSure Lung can detect signs of rejection or infection in lung transplant recipients. Researchers will follow 550 people who have had a lung transplant and use the test to monitor their health. The goal is to see if the test is ac…